Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 -0.0670886075949366 -0.0780590717299578
Stock impact report

AzurRx BioPharma Reaches Enrollment Target for Phase II OPTION Clinical Trial

AzurRx BioPharma, Inc. (AZRX) 
Last azurrx biopharma, inc. earnings: 11/14 04:31 pm Check Earnings Report
Company Research Source: GlobeNewswire
Enrollment in AzurRx’s Phase II OPTION study has reached target of 30-35 patientsScreening activities have been completed in AzurRx’s Phase II Option studyTop-line data expected in Summer 2019 NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has reached its enrollment target of 30-35 patients in its ongoing Phase II OPTION study of MS1819-SD for exocrine pancreatic insufficiency in patients with cystic fibrosis (CF).  The Company has completed screening activities for enrollment of the study, which is taking place across investigative sites in North America and Poland. Top-line results for the OPTION study are expected in Summer 2019. The Phase II multi-center OPTION study is designed to investigate the safety, tolerability and efficacy of MS1819-SD in a head-to-head comparison against t Show less Read more
Impact Snapshot
Event Time:
AZRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AZRX alerts
Opt-in for
AZRX alerts

from News Quantified
Opt-in for
AZRX alerts

from News Quantified